Insights
Evidence, briefs and structural thinking on rare disease.
White papers and strategic briefs on the clinical, regulatory and data infrastructure of rare disease.
Featured strategic brief
Bringing Small Molecules to Life
A structural view of how rare disease small molecules can be translated across the Boston–Brazil corridor.
Editorial pillars
What we write about.
01
Rare disease infrastructure
How the pathway from molecule to patient is actually assembled.
02
Brazil as a clinical environment
Regulatory, institutional and cohort perspectives.
03
Data and bioinformatics
Evidence, governance and platform design.
04
Boston ↔ Brazil corridor
Translation between two of the world's rare disease ecosystems.
05
Access and real-world evidence
Reimbursement, continuity, longitudinal data.
Subscribe
Receive our strategic briefs
Occasional publications for rare disease developers, investigators and investors.
Pharma²⁸
Let's connect.
If you are exploring international opportunities for a rare disease therapy, clinical program, data initiative or strategic partnership, we would welcome the opportunity to connect.